Short Interest: Is Staar Surgical Company (NASDAQ:STAA) a Buy? The Stock Reported Less Sellers

November 16, 2016 - By kentuckypostne   ·   0 Comments

Short Interest: Is Staar Surgical Company (NASDAQ:STAA) a Buy? The Stock Reported Less Sellers

The stock of Staar Surgical Company (NASDAQ:STAA) registered a decrease of 2.94% in short interest. STAA’s total short interest was 1.88 million shares in November as published by FINRA. Its down 2.94% from 1.94 million shares, reported previously. With 83,400 shares average volume, it will take short sellers 23 days to cover their STAA’s short positions. The short interest to Staar Surgical Company’s float is 7.62%. About 54,335 shares traded hands. STAAR Surgical Company (NASDAQ:STAA) has risen 36.72% since April 14, 2016 and is uptrending. It has outperformed by 32.03% the S&P500.

STAAR Surgical Company designs, develops, makes and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company has a market cap of $426.40 million. The Firm operates in the ophthalmic surgical market segment. It currently has negative earnings. The Company’s principal products are intraocular lenses used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.

Insitutional Activity: The institutional sentiment increased to 1.31 in 2016 Q2. Its up 0.17, from 1.14 in 2016Q1. The ratio increased, as 6 funds sold all STAAR Surgical Company shares owned while 20 reduced positions. 7 funds bought stakes while 27 increased positions. They now own 29.99 million shares or 0.42% less from 30.12 million shares in 2016Q1.
Palo Alto Limited Liability reported 3.21 million shares or 1.33% of all its holdings. Prudential, a New Jersey-based fund reported 14,009 shares. Stephens Ar last reported 0% of its portfolio in the stock. Wells Fargo And Mn, a California-based fund reported 39,441 shares. Deutsche Bancshares Ag reported 67,317 shares or 0% of all its holdings. Nomura last reported 23,160 shares in the company. Grandeur Peak Glob Ltd Liability Company accumulated 582,861 shares or 0.86% of the stock. Zurcher Kantonalbank (Zurich Cantonalbank) last reported 0% of its portfolio in the stock. Morgan Stanley accumulated 596,096 shares or 0% of the stock. Gsa Capital Ptnrs Limited Liability Partnership holds 38,387 shares or 0.01% of its portfolio. Moreover, State Board Of Administration Of Florida Retirement has 0% invested in STAAR Surgical Company (NASDAQ:STAA) for 28,799 shares. The Illinois-based Northern Trust has invested 0% in STAAR Surgical Company (NASDAQ:STAA). Secor Ltd Partnership accumulated 0.02% or 25,866 shares. Bnp Paribas Arbitrage Sa accumulated 1,547 shares or 0% of the stock. Kennedy Management Inc has invested 0.02% of its portfolio in STAAR Surgical Company (NASDAQ:STAA).

Insider Transactions: Since May 17, 2016, the stock had 2 buys, and 0 sales for $475,810 net activity. BROADWOOD PARTNERS LP also bought $74,081 worth of STAAR Surgical Company (NASDAQ:STAA) shares. The insider MEIER RICHARD A sold 25,000 shares worth $133,849.

STAA Company Profile

STAAR Surgical Company (STAAR), incorporated on April 3, 1986, designs, develops, makes and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Firm operates in the ophthalmic surgical market segment. The Company’s principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. The Firm makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. The Firm operates under the brands STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX nanoPOINT, Epiphany and AquaFlow. Collamer is the brand name for STAAR’s collagen copolymer lens material. STAAR sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

More notable recent STAAR Surgical Company (NASDAQ:STAA) news were published by: Prnewswire.com which released: “STAAR Surgical to Report Third Quarter Results on November 3, 2016” on October 20, 2016, also Prnewswire.com with their article: “STAAR Surgical Reports First Quarter 2016 Results” published on May 11, 2016, Prnewswire.com published: “STAAR Surgical Announces Strategic Cooperation Agreement With World Eye …” on September 07, 2016. More interesting news about STAAR Surgical Company (NASDAQ:STAA) were released by: Prnewswire.com and their article: “STAAR Surgical Reports Second Quarter 2016 Results” published on August 03, 2016 as well as Prnewswire.com‘s news article titled: “STAAR Surgical Company and Memira Holding Announce Cooperation Agreement for …” with publication date: February 09, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By kentuckypostne


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>